iver MaP - A Pilot Study of FDGal-PET and Dynamic MRI Evaluation of Regional Liver Function in Patients with Liver Cancer Undergoing Surgery or Stereotactic Radiation Therapy.
Not Applicable
Recruiting
- Conditions
- Patients with Liver CancerCancer - Liver
- Registration Number
- ACTRN12619001499178
- Lead Sponsor
- Metro South Hospital and Health Services (Princess Alexandra Hospital)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
•Diagnosis of primary liver cancer
•Aged 18 or older
•ECOG performance status 0-2
•Diagnostic quality CT or MRI within 6 weeks of study entry.
•Planned to undergo either surgical resection or SBRT
•Prior liver directed or systemic therapies allowed.
•Has provided written Informed Consent for participation in this trial and is willing to comply with the study requirements and follow-up.
Exclusion Criteria
•Patient unable to undergo MRI (e.g. non compatible pacemakers)
•Allergic reaction attributed to compounds of similar composition to ICG, including those patients with a history of iodine or seafood allergy.
•Women who are pregnant or lactating
•Unwilling or unable to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method